Global Glucagon-like Peptide-2 (GLP-2) Agonist Supply, Demand and Key Producers, 2024-2030

Page: 82

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to reach $ 2094.9 million by 2030, rising at a market growth of 15.3% CAGR during the forecast period (2024-2030).

The Teduglutide market is primarily driven by the demand for innovative therapies to address short bowel syndrome (SBS) and improve the quality of life for affected patients. Teduglutide is a medication used to treat SBS, a condition characterized by impaired intestinal function due to surgical resection or congenital anomalies. The limited treatment options for SBS, coupled with advancements in gastrointestinal medicine and patient-centric care, contribute to market growth. Moreover, the demonstrated efficacy of Teduglutide in reducing dependence on parenteral nutrition and enhancing nutrient absorption further propels adoption. However, challenges include managing potential side effects and addressing patient access issues. Navigating regulatory approvals, optimizing treatment regimens, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in gastrointestinal disorders, collaborations between pharmaceutical manufacturers and gastroenterologists, and comprehensive patient education on the benefits and potential risks of Teduglutide treatment while addressing the evolving challenges associated with SBS management and treatment accessibility.

Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.

This report studies the global Glucagon-like Peptide-2 (GLP-2) Agonist production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Glucagon-like Peptide-2 (GLP-2) Agonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Glucagon-like Peptide-2 (GLP-2) Agonist that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Glucagon-like Peptide-2 (GLP-2) Agonist total production and demand, 2019-2030, (K Units)
Global Glucagon-like Peptide-2 (GLP-2) Agonist total production value, 2019-2030, (USD Million)
Global Glucagon-like Peptide-2 (GLP-2) Agonist production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Glucagon-like Peptide-2 (GLP-2) Agonist consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Glucagon-like Peptide-2 (GLP-2) Agonist domestic production, consumption, key domestic manufacturers and share
Global Glucagon-like Peptide-2 (GLP-2) Agonist production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Glucagon-like Peptide-2 (GLP-2) Agonist production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Glucagon-like Peptide-2 (GLP-2) Agonist production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Glucagon-like Peptide-2 (GLP-2) Agonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Glucagon-like Peptide-2 (GLP-2) Agonist market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, Segmentation by Type
    Gattex
    Revestive

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, Segmentation by Application
    Hospital
    Pharmacy
    Other

Companies Profiled:
    Takeda Pharmaceuticals

Key Questions Answered
1. How big is the global Glucagon-like Peptide-2 (GLP-2) Agonist market?
2. What is the demand of the global Glucagon-like Peptide-2 (GLP-2) Agonist market?
3. What is the year over year growth of the global Glucagon-like Peptide-2 (GLP-2) Agonist market?
4. What is the production and production value of the global Glucagon-like Peptide-2 (GLP-2) Agonist market?
5. Who are the key producers in the global Glucagon-like Peptide-2 (GLP-2) Agonist market?

Table of Contents

1 Supply Summary
    1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Introduction
    1.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Supply & Forecast
        1.2.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value (2019 & 2023 & 2030)
        1.2.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2030)
        1.2.3 World Glucagon-like Peptide-2 (GLP-2) Agonist Pricing Trends (2019-2030)
    1.3 World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region (Based on Production Site)
        1.3.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Region (2019-2030)
        1.3.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region (2019-2030)
        1.3.3 World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Region (2019-2030)
        1.3.4 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Glucagon-like Peptide-2 (GLP-2) Agonist Major Market Trends

2 Demand Summary
    2.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Demand (2019-2030)
    2.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption by Region
        2.2.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption by Region (2019-2024)
        2.2.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Forecast by Region (2025-2030)
    2.3 United States Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)
    2.4 China Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)
    2.5 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)
    2.6 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)
    2.7 South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)
    2.8 ASEAN Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)
    2.9 India Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030)

3 World Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers Competitive Analysis
    3.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Manufacturer (2019-2024)
    3.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Manufacturer (2019-2024)
    3.3 World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Manufacturer (2019-2024)
    3.4 Glucagon-like Peptide-2 (GLP-2) Agonist Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Glucagon-like Peptide-2 (GLP-2) Agonist in 2023
        3.5.3 Global Concentration Ratios (CR8) for Glucagon-like Peptide-2 (GLP-2) Agonist in 2023
    3.6 Glucagon-like Peptide-2 (GLP-2) Agonist Market: Overall Company Footprint Analysis
        3.6.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market: Region Footprint
        3.6.2 Glucagon-like Peptide-2 (GLP-2) Agonist Market: Company Product Type Footprint
        3.6.3 Glucagon-like Peptide-2 (GLP-2) Agonist Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Comparison
        4.1.1 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Comparison
        4.2.1 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Comparison
        4.3.1 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2024)
    4.5 China Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers and Market Share
        4.5.1 China Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value (2019-2024)
        4.5.3 China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2024)
    4.6 Rest of World Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2024)

5 Market Analysis by Type
    5.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Gattex
        5.2.2 Revestive
    5.3 Market Segment by Type
        5.3.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Type (2019-2030)
        5.3.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Type (2019-2030)
        5.3.3 World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Application (2019-2030)
        6.3.2 World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Application (2019-2030)
        6.3.3 World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Takeda Pharmaceuticals
        7.1.1 Takeda Pharmaceuticals Details
        7.1.2 Takeda Pharmaceuticals Major Business
        7.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product and Services
        7.1.4 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Takeda Pharmaceuticals Recent Developments/Updates
        7.1.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Glucagon-like Peptide-2 (GLP-2) Agonist Industry Chain
    8.2 Glucagon-like Peptide-2 (GLP-2) Agonist Upstream Analysis
        8.2.1 Glucagon-like Peptide-2 (GLP-2) Agonist Core Raw Materials
        8.2.2 Main Manufacturers of Glucagon-like Peptide-2 (GLP-2) Agonist Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Glucagon-like Peptide-2 (GLP-2) Agonist Production Mode
    8.6 Glucagon-like Peptide-2 (GLP-2) Agonist Procurement Model
    8.7 Glucagon-like Peptide-2 (GLP-2) Agonist Industry Sales Model and Sales Channels
        8.7.1 Glucagon-like Peptide-2 (GLP-2) Agonist Sales Model
        8.7.2 Glucagon-like Peptide-2 (GLP-2) Agonist Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Region (2019-2024)
    Table 5. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Region (2025-2030)
    Table 6. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region (2019-2024) & (K Units)
    Table 7. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region (2025-2030) & (K Units)
    Table 8. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share by Region (2019-2024)
    Table 9. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share by Region (2025-2030)
    Table 10. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Region (2019-2024) & (USD/Unit)
    Table 11. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Region (2025-2030) & (USD/Unit)
    Table 12. Glucagon-like Peptide-2 (GLP-2) Agonist Major Market Trends
    Table 13. World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption by Region (2019-2024) & (K Units)
    Table 15. World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Glucagon-like Peptide-2 (GLP-2) Agonist Producers in 2023
    Table 18. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Glucagon-like Peptide-2 (GLP-2) Agonist Producers in 2023
    Table 20. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 21. Global Glucagon-like Peptide-2 (GLP-2) Agonist Company Evaluation Quadrant
    Table 22. World Glucagon-like Peptide-2 (GLP-2) Agonist Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Glucagon-like Peptide-2 (GLP-2) Agonist Production Site of Key Manufacturer
    Table 24. Glucagon-like Peptide-2 (GLP-2) Agonist Market: Company Product Type Footprint
    Table 25. Glucagon-like Peptide-2 (GLP-2) Agonist Market: Company Product Application Footprint
    Table 26. Glucagon-like Peptide-2 (GLP-2) Agonist Competitive Factors
    Table 27. Glucagon-like Peptide-2 (GLP-2) Agonist New Entrant and Capacity Expansion Plans
    Table 28. Glucagon-like Peptide-2 (GLP-2) Agonist Mergers & Acquisitions Activity
    Table 29. United States VS China Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Glucagon-like Peptide-2 (GLP-2) Agonist Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share (2019-2024)
    Table 37. China Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share (2019-2024)
    Table 42. Rest of World Based Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share (2019-2024)
    Table 47. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Type (2019-2024) & (K Units)
    Table 49. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Type (2025-2030) & (K Units)
    Table 50. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Type (2019-2024) & (USD/Unit)
    Table 53. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Type (2025-2030) & (USD/Unit)
    Table 54. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Application (2019-2024) & (K Units)
    Table 56. World Glucagon-like Peptide-2 (GLP-2) Agonist Production by Application (2025-2030) & (K Units)
    Table 57. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Application (2019-2024) & (USD/Unit)
    Table 60. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Application (2025-2030) & (USD/Unit)
    Table 61. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 62. Takeda Pharmaceuticals Major Business
    Table 63. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product and Services
    Table 64. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Global Key Players of Glucagon-like Peptide-2 (GLP-2) Agonist Upstream (Raw Materials)
    Table 66. Glucagon-like Peptide-2 (GLP-2) Agonist Typical Customers
    Table 67. Glucagon-like Peptide-2 (GLP-2) Agonist Typical Distributors
List of Figure
    Figure 1. Glucagon-like Peptide-2 (GLP-2) Agonist Picture
    Figure 2. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2030) & (K Units)
    Figure 5. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price (2019-2030) & (USD/Unit)
    Figure 6. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Region (2019-2030)
    Figure 7. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share by Region (2019-2030)
    Figure 8. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Production (2019-2030) & (K Units)
    Figure 9. Glucagon-like Peptide-2 (GLP-2) Agonist Market Drivers
    Figure 10. Factors Affecting Demand
    Figure 11. World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 12. World Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Market Share by Region (2019-2030)
    Figure 13. United States Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 14. China Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 15. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 16. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 17. South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 18. ASEAN Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 19. India Glucagon-like Peptide-2 (GLP-2) Agonist Consumption (2019-2030) & (K Units)
    Figure 20. Producer Shipments of Glucagon-like Peptide-2 (GLP-2) Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 21. Global Four-firm Concentration Ratios (CR4) for Glucagon-like Peptide-2 (GLP-2) Agonist Markets in 2023
    Figure 22. Global Four-firm Concentration Ratios (CR8) for Glucagon-like Peptide-2 (GLP-2) Agonist Markets in 2023
    Figure 23. United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 24. United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 25. United States VS China: Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 26. United States Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share 2023
    Figure 27. China Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share 2023
    Figure 28. Rest of World Based Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share 2023
    Figure 29. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Type in 2023
    Figure 31. Gattex
    Figure 32. Revestive
    Figure 33. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share by Type (2019-2030)
    Figure 34. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Type (2019-2030)
    Figure 35. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Type (2019-2030) & (USD/Unit)
    Figure 36. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Application in 2023
    Figure 38. Hospital
    Figure 39. Pharmacy
    Figure 40. Other
    Figure 41. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Market Share by Application (2019-2030)
    Figure 42. World Glucagon-like Peptide-2 (GLP-2) Agonist Production Value Market Share by Application (2019-2030)
    Figure 43. World Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Application (2019-2030) & (USD/Unit)
    Figure 44. Glucagon-like Peptide-2 (GLP-2) Agonist Industry Chain
    Figure 45. Glucagon-like Peptide-2 (GLP-2) Agonist Procurement Model
    Figure 46. Glucagon-like Peptide-2 (GLP-2) Agonist Sales Model
    Figure 47. Glucagon-like Peptide-2 (GLP-2) Agonist Sales Channels, Direct Sales, and Distribution
    Figure 48. Methodology
    Figure 49. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Takeda Pharmaceuticals

Related Reports

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.

Global Glucagon-like Peptide-2 (GLP-2) Agonist Supply, Demand and Key Producers, 2023-2029

Global Glucagon-like Peptide-2 (GLP-2) Agonist Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Glucagon-like Peptide-2 (GLP-2) Agonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Glucagon-like Peptide-2 (GLP-2) Agonist market size was valued at USD 772.7 million in 2023 and is forecast to a readjusted size of USD 2094.9 million by 2030 with a CAGR of 15.3% during review period.

Product Tags

Glucagon-like Peptide-2 (GLP-2) Agonist

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>